ArticleiScience2026
Complex biological systems analysis and deep learning for prognostic prediction of esophageal squamous cell carcinoma.
Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Esophageal squamous cell carcinoma (ESCC) prognosis remains poor, and traditional models often fail to capture complex nonlinear interactions between clinical and molecular features. We integrated transcriptomic data from public datasets and an independent clinical cohort to identify prognostic biomarkers. Using weighted gene co-expression network analysis (WGCNA) and Lasso-Cox regression, we identified 16 key genes to construct a deep learning-based survival model, DeepSurv, integrating clinical and genetic features. DeepSurv demonstrated superior predictive performance compared to conventional machine learning models in both internal and external validation cohorts. SHAP value analysis highlighted the contribution of specific genes, including FAM155B and CFHR4, alongside TNM stages. This study establishes a robust, multidimensional prognostic tool that enhances risk stratification and offers insights into the molecular mechanisms driving ESCC progression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.